LRRK2 and Parkinson disease: 14-3-3θ overexpression reduces toxicity in multiple PD models, including neurotoxin, αsyn, and LRRK2 models (Yacoubian et al., 2010; Slone et al., 2011; Ding et al., 2015; Lavalley et al., 2016; Wang et al., 2018).